Deals channel feed – Endpoints News

Deals channel feed

Galapagos pauses blood cancer CAR-T therapy trial due to one Parkinsonism event

9 months ago

Vir's overhaul brings an end to most virology work — and a beginning with cancer

9 months ago

AbbVie closes $8.7B Cerevel deal in bid to compete with Bristol Myers in schizophrenia

9 months ago

Updated: Otsuka buys out small molecule drug discovery startup Jnana and its rare disease pill for $800M cash

9 months ago

Biosecure lawmakers tell trade groups that China studies are a new focus

9 months ago

Behind Boehringer’s up to $1.3B Nerio deal is a budding cancer pipeline and aim to ‘leapfrog AbbVie’

9 months ago

Boehringer Ingelheim buys oncology biotech for up to $1.3B

9 months ago

NewAmsterdam succeeds in the first of three key pivotal studies, providing hope to a troubled cardio class

9 months ago

Updated: GSK and Flagship to create up to 10 vaccines, medicines across respiratory and immunology

9 months ago

Ipsen pays Day One $111M upfront for ex-US rights to pediatric brain tumor drug

9 months ago

In a tough market, private biotechs pursue IPOs and buyouts at the same time

9 months ago

Novartis pays $150M upfront, including $25M in equity, for Dren Bio’s bispecifics

9 months ago

BioNTech signs 3D printing deal to develop oral RNA drugs

9 months ago

AstraZeneca signs preclinical EGFR drug deal with antibody biotech

9 months ago

Health tech startup Commure bets on AI for medical notes in $139M deal

9 months ago

Agilent Technologies to acquire CDMO Biovectra for $925M

9 months ago

HI-Bio dishes on motivations for Biogen buyout, citing desire to move fast

9 months ago

Roivant recently sold one spinout for billions. Is Priovant next?

9 months ago

Corrected: Lilly upped its offer for Morphic by $11 per share, documents show

9 months ago

J&J ditches epilepsy development with Addex, blindsiding 20-year partner

9 months ago

‘Search mode’: Human challenge trial company looks to buy small CROs

9 months ago

Genentech parts ways with Relay Therapeutics on SHP2 after other pharma exits

9 months ago

Sionna licenses clinical-stage cystic fibrosis assets from AbbVie shortly after large Series C

10 months ago

After last year's ImmunoGen pact, Vertex finds another conditioning agent partner in Orum

10 months ago

First page Previous page 11 12 131415 16 17 Next page Last page